Showing 581-590 of 5608 results for "".
Time Is Your Friend
https://crstoday.com/topics/practice-management/time-is-your-friend/44041/For some patients, patience is necessary.Improving Fluid Dynamics in Laser Cataract Surgery
https://crstoday.com/topics/cataract-surgery/improving-fluid-dynamics-in-laser-cataract-surgery/43952/The design of existing phaco tips leads to instability in the anterior chamber. A new tip was designed to address the issue.Matching Glaucoma Patient Needs With the Right Procedure
https://crstoday.com/crst-supplements/matching-glaucoma-patient-needs-with-the-right-procedure/matching-glaucoma-patient-needs-with-the-right-procedure-copy/43706/Where new technologies fit in my practice.My Pharmaceutical Wish List
https://crstoday.com/topics/general/my-pharmaceutical-wish-list/42452/This surgeon desires changes and developments that will bring about more efficacious therapy.Is Presbyopia Finally Taking Center Stage?
https://crstoday.com/crst-supplements/is-presbyopia-finally-taking-center-stage/is-presbyopia-finally-taking-center-stage-2/44714/White Cataract After Open Globe Repair in a Child
https://crstoday.com/crst-issues/2017-jul/white-cataract-after-open-globe-repair-in-a-child/43467/The Right to Select the Best Biomaterials for Your Patients
https://crstoday.com/crst-supplements/the-right-to-select-the-best-biomaterials-for-your-patients/the-right-to-select-the-best-biomaterials-for-your-patients/45356/Graftless Corneal Endothelial Replacement
https://crstoday.com/topics/cornea/graftless-corneal-endothelial-replacement/44239/A new treatment paradigm in Fuchs dystrophy.How to Create a Successful Dry Eye Practice
https://crstoday.com/topics/general/how-to-create-a-successful-dry-eye-practice/43036/The dollars and sense of a dry eye clinic.Perioperative Drug Delivery: Improved Compliance, Lower Cost
https://crstoday.com/topics/general/perioperative-drug-delivery-improved-compliance-lower-cost/43174/Fixed-combination medications given at the time of surgery may help streamline postoperative care.